nigericin has been researched along with Agammaglobulinemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunner, C; Daiber, E; Dang, TM; Delmiro Garcia, M; Dickhöfer, S; Dillen, C; Franz-Wachtel, M; Grimbacher, B; Hartl, D; Kraus, H; Kümmerle-Deschner, J; Latz, E; Liu, X; Macek, B; Miller, L; Münzenmayer, L; Pichulik, T; Radsak, M; Rieber, N; Schulte, B; Stilgenbauer, S; Stutz, A; Vogel, S; Wahl, S; Walz, JS; Weber, ANR; Wolz, C; Wolz, OO; Yazdi, A | 1 |
1 other study(ies) available for nigericin and Agammaglobulinemia
Article | Year |
---|---|
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Topics: Adaptive Immunity; Adaptor Proteins, Signal Transducing; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Animals; Apoptosis Regulatory Proteins; Bacterial Proteins; Cells, Cultured; Cryopyrin-Associated Periodic Syndromes; Genetic Diseases, X-Linked; Humans; Immunity, Innate; Inflammasomes; Lamin B Receptor; Leukocidins; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Targeted Therapy; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins; Protein-Tyrosine Kinases; Proteomics; Pyrin Domain; Receptors, Cytoplasmic and Nuclear; Staphylococcal Infections; Staphylococcus aureus | 2017 |